Group items tagged

Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease of the liver. The auto-immune disorder can have a number of symptoms such as abdominal pain, fever, nausea, vomiting, abdominal bloating, diarrhea, liver tenderness or enlargement, jaundice, and ascites. In most of these symptoms, the patient may be experiencing inflammation at an early stage of the illness, although in some cases, symptoms do not appear until the disease has advanced to a more serious state. A definitive diagnosis can only be made by performing blood tests and ultrasound studies in order to determine the progression of the illness and its effects on the body. At an early stage, most patients who experience mild to moderate symptoms of primary biliary cholangitis exhibit no symptoms, whereas in some cases, symptoms manifest very quickly and rapidly worsen. In both conditions, the majority of affected individuals undergo treatment that is aimed at relieving pain and treating any complications that might occur. High prevalence of primary biliary cholangitis is expected to propel growth of the primary biliary cirrhosis drugs market. For instance, according to the study, 'Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis', published in Hepatology International in September 2019, the overall prevalence of primary biliary cholangitis was 118.75 cases per million in the Asia Pacific region, with the high, medium and low prevalence being in Japan and China (191.18 cases per million), New Zealand (99.16 cases per million) and South Korea and Australia (39.09 cases per million), respectively. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-primary-biliary.html

Breast implants are classified as class III higher risk medical devices used to augment the size of the breasts, either for reconstruction purposes or cosmetic applications. There are two types of breast implants, such as saline breast implants and silicone breast implants. Both implants are considered safe for breast reconstruction and breast augmentation. However, research on the safety and effectiveness of the implant is ongoing. Silicone implants tend to feel more like natural breast tissue than saline alternatives. With the increasing prevalence of breast cancer, the demand for breast implants is also increasing. The difference between breast implants and breast augmentation is quite simple; breast implants are synthetic parts that are surgically inserted to support the growth process, whereas breast augmentation is a category of procedures that enlarge the breast size. Today's breast implants, on average, are designed to last more than a decade. In many cases, breast implants can remain in good shape for 20 years or more. A breast implant is a postoperative prosthetic designed to change the physical appearance, size, and shape of the breasts. In reconstructive plastic surgery, breast implants are placed into one or both breasts to restore a natural appearance to the wearer. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/08/breast-implants-prosthesis-used-to.html

Omega-3 fatty acids present in fish oil play a significant role in enhancing health of men. Decreased intake of omega-3 fatty acid and circulating range of DHA (Docosahexaenoic acid) in the body of men leads to the risk of enlarged prostate or BPH (Benign Prostatic Hyperplasia), prostatitis or prostate cancer.